Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation

被引:64
作者
Hoermannsperger, Gabriele [1 ]
Clavel, Thomas [1 ]
Hoffmann, Micha [1 ]
Reiff, Caroline [2 ]
Kelly, Denise [2 ]
Loh, Gunnar [3 ]
Blaut, Michael [3 ]
Hoelzlwimmer, Gabriele [4 ]
Laschinger, Melanie [5 ]
Haller, Dirk [1 ]
机构
[1] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Chair Biofunct, D-8050 Freising Weihenstephan, Germany
[2] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB9 1FX, Scotland
[3] Deutsches Inst Ernahrungsforsch, Potsdam, Germany
[4] Helmholz Zent Munchen, Inst Pathol, Munich, Germany
[5] Tech Univ Munich, Dept Surg, Munich, Germany
关键词
D O I
10.1371/journal.pone.0004365
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). Methodology/Principal Findings: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF Delta ARE and IL-10(-/-) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(-/-) mice, IP-10 protein expression was reduced in primary epithelial cells. Conclusions/Significance: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.
引用
收藏
页数:17
相关论文
共 52 条
[1]
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut [J].
Artis, David .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (06) :411-420
[2]
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease [J].
Banks, C ;
Bateman, A ;
Payne, R ;
Johnson, P ;
Sheron, N .
JOURNAL OF PATHOLOGY, 2003, 199 (01) :28-35
[3]
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis [J].
Bibiloni, R ;
Fedorak, RN ;
Tannock, GW ;
Madsen, KL ;
Gionchetti, P ;
Campieri, M ;
De Simone, C ;
Sartor, RB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1539-1546
[4]
Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity [J].
Campanella, Gabriele S. V. ;
Grimm, Jan ;
Manice, Lindsay A. ;
Colvin, Richard A. ;
Medoff, Benjamin D. ;
Wojtkiewicz, Gregory R. ;
Weissleder, Ralph ;
Luster, Andrew D. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (10) :6991-6998
[5]
VSL#3 probiotic mixture - A review of its use in chronic inflammatory bowel diseases [J].
Chapman, Therese M. ;
Plosker, Greg L. ;
Figgitt, David P. .
DRUGS, 2006, 66 (10) :1371-1387
[6]
The genetics and immunopathogenesis of inflammatory bowel disease [J].
Cho, Judy H. .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (06) :458-466
[7]
Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammation [J].
Clovel, Thomas ;
Holler, Dirk .
INFLAMMATORY BOWEL DISEASES, 2007, 13 (09) :1153-1164
[8]
Fractionation analysis of the endosomal compartment during rat reticulocyte maturation [J].
Dardalhon, V ;
Géminard, C ;
Reggio, H ;
Vidal, M ;
Sainte-Marie, J .
CELL BIOLOGY INTERNATIONAL, 2002, 26 (08) :669-678
[9]
Giacinto CD, 2005, J IMMUNOL, V174, P3237
[10]
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Venturi, A ;
Brigidi, P ;
Matteuzzi, D ;
Bazzocchi, G ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2000, 119 (02) :305-309